Switzerland drug approvals | Swissmedic news | Blogs | 2023 | iPharmaCenter
- ipharmaservices
- Jul 10, 2023
- 0 min read
top of page
Search
Recent Posts
See AllCHMP gave a positive opinion for treating BMS' cell-therapy Breyanzi for relapsed or refractory follicular lymphoma Bristol Myers Squibb...
The European Commission has granted approval for the use of Rybrevant ( amivantamab) in combination with Lazcluze ( lazertinib) as a...
The European Commission (EC) has approved Kisqali (ribociclib) in combination with aromatase inhibitors (AI) for the treatment of...
bottom of page
Comments